Down-regulation of GluK2 kainate receptor expression by chronic treatment with mood-stabilizing anti-convulsants or lithium in cultured astrocytes and brain, but not in neurons

Neuropharmacology

Volumn 57, Issue 4, 2009, Pages 375-385

  Li, Baoman ^a   Zhang, Shiquen ^a   Li, Min ^a   Zhang, Hongyan ^a   Hertz, Leif ^a   Peng, Liang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bipolar disorder; Carbamazepine; ERK phosphorylation; Lithium; Mood stabilizing anti convulsants; Valproic acid

Indexed keywords

CARBAMAZEPINE; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR 2; KAINIC ACID RECEPTOR 3; KAINIC ACID RECEPTOR 4; KAINIC ACID RECEPTOR 5; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; REGULATORY MECHANISM; SYNAPTIC TRANSMISSION;

ANIMALS; ANTICONVULSANTS; ASTROCYTES; BRAIN; CELLS, CULTURED; CEREBELLUM; CEREBRUM; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HIPPOCAMPUS; LITHIUM COMPOUNDS; MALE; MICE; NEURONS; PSYCHOTROPIC DRUGS; RECEPTORS, KAINIC ACID; RNA, MESSENGER;

EID: 68749087012     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.07.004     Document Type: Article

References (40)

1. Alloisio S., Aiello R., Ferroni S., and Nobil M. Potentiation of native and recombinant P2X7-mediated calcium signaling by arachidonic acid in cultured cortical astrocytes and human embryonic kidney 293 cells. Mol. Pharmacol. 69 (2006) 1975-1983
2. Benes F.M., Lim B., Matzilevich D., Walsh J.P., Subburaju S., and Minns M. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 10164-10169
3. Beneyto M., Kristiansen L.V., Oni-Orisan A., McCullumsmith R.E., and Meador-Woodruff J.H. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32 (2007) 1888-1902
4. Brand-Schieber E., Lowery S.L., and Werner P. Select ionotropic glutamate AMPA/kainate receptors are expressed at the astrocyte-vessel interface. Brain Res. 1007 (2004) 178-182
5. Bureau I., Dieudonne S., Coussen F., and Mulle C. Kainate receptor-mediated synaptic currents in cerebellar Golgi cells are not shaped by diffusion of glutamate. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6838-6843
6. Cahoy J.D., Emery B., Kaushal A., Foo L.C., Zamanian J.L., Christopherson K.S., Xing Y., Lubischer J.L., Krieg P.A., Krupenko S.A., Thompson W.J., and Barres B.A. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28 (2008) 264-278
7. Engel S.R., Creson T.K., Hao Y., Shen Y., Maeng S., Nekrasova T., Landreth G.E., Manji H.K., and Chen G. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol. Psychiatry 14 (2009) 448-461
8. Fuller G., Veitch K., Ho L.K., Cruise L., and Morris B.J. Activation of p44/p42 MAP kinase in striatal neurons via kainate receptors and PI3 kinase. Mol. Brain Res. 89 (2001) 126-132
9. Goodnick P.J. Anti-convulsants in the treatment of bipolar mania. Expert. Opin. Pharmacother. 7 (2006) 401-410
10. Gualtieri C.T., and Johnson L.G. Comparative neurocognitive effects of 5 psychotropic anti-convulsants and lithium. Med. Gen. Med. 8 (2006) 46
11. Halassa M.M., Fellin T., Takano H., Dong J.H., and Haydon P.G. Synaptic islands defined by the territory of a single astrocyte. J. Neurosci. 27 (2007) 6473-6477
12. Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., Gould T.D., Manji H.K., and Chen G. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J. Neurosci. 24 (2004) 6590-6599
13. Hertz L. Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology 55 (2008) 289-309
14. Hertz L., Juurlink B.H.J., and Szuchet S. Cell cultures. In: Lajtha A. (Ed). Handbook of Neurochemistry. second ed. vol. 8 (1985), Plenum Press, New York 603-661
15. Hertz L., Peng L., and Lai J.C. Functional studies in cultured astrocytes. Methods 16 (1998) 293-310
16. Jane D.E., Lodge D., and Collingridge G.L. Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology 56 (2009) 90-113
17. 2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration. Neurochem. Int. 27 (2002) 113-120
18. Lee S.H., Lee J.G., Kim J.R., and Baek S.H. Toll-like receptor 9-mediated cytosolic phospholipase A2 activation regulates expression of inducible nitric oxide synthase. Biochem. Biophys. Res. Commun. 364 (2007) 996-1001
19. Li B., Gu L., Zhang H., Huang J., Chen Y., Hertz L., and Peng L. Up-regulation of cPLA(2) gene expression in astrocytes by all three conventional anti-bipolar drugs is drug-specific and enzyme-specific. Psychopharmacology (Berl.) 194 (2007) 333-345
20. Lubrich B., and van Calker D. Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of anti-bipolar drugs?. Neuropsychopharmacology 21 (1999) 519-529
21. Mao L., Tang Q., Samdani S., Liu Z., and Wang J.Q. Regulation of MAPK/ERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons. Eur. J. Neurosci. 19 (2004) 1207-1216
22. el-Marjou A., Delouvée A., Thiery J.P., and Radvanyi F. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression. Carcinogenesis 21 (2000) 2211-2218
23. McGrath B.M., Greenshaw A.J., McKay R., Slupsky C.M., and Silverstone P.H. Lithium alters regional rat brain myo-inositol at 2 and 4 weeks: an ex-vivo magnetic resonance spectroscopy study at 18.8 T. Neuroreport 17 (2006) 1323-1326
24. Meier E., Hertz L., and Schousboe A. Neurotransmitters as developmental signals. Neurochem. Int. 19 (1991) 1-15
25. Nadkarni S., and Jung P. Modeling synaptic transmission of the tripartite synapse. Phys. Biol. 4 (2007) 1-9
26. Pardo R., Andreolotti A.G., Ramos B., Picatoste F., and Claro E. Opposed effects of lithium on the MEK-ERK pathway in neural cells: inhibition in astrocytes and stimulation in neurons by GSK3 independent mechanisms. J. Neurochem. 87 (2003) 417-426
27. Paschen W., Schmitt J., and Uto A. RNA editing of glutamate receptor subunits GluR2, GluR5 and GluR6 in transient cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 16 (1996) 548-556
28. Peng L., Juurlink B.H.J., and Hertz L. Differences in transmitter release, morphology and ischemia-induced cell injury between cerebellar granule cell cultures developing in the presence and in the absence of a depolarizing potassium concentration. Dev. Brain Res. 63 (1991) 1-12
29. Popova E., Leighton C., Bernabarre A., Bernardo M., and Vieta E. Oxcarbazepine in the treatment of bipolar and schizoaffective disorders. Expert. Rev. Neurother. 7 (2007) 617-626
30. Ruiz A., Sachidhanandam S., Utvik J.K., Coussen F., and Mulle C. Distinct subunits in heteromeric kainate receptors mediate ionotropic and metabotropic function at hippocampal mossy fiber synapses. J. Neurosci. 25 (2005) 11710-11718
31. Sanacora G., Zarate C.A., Krystal J.H., and Manji H.K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug Discov. 7 (2008) 426-437
32. Schulze T.G., Buervenich S., Badner J.A., Steele C.J., Detera-Wadleigh S.D., Dick D., Foroud T., Cox N.J., MacKinnon D.F., Potash J.B., Berrettini W.H., Byerley W., Coryell W., DePaulo Jr. J.R., Gershon E.S., Kelsoe J.R., McInnis M.G., Murphy D.L., Reich T., Scheftner W., Nurnberger Jr. J.I., and McMahon F.J. Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the National Institute of Mental health genetics initiative pedigrees. Biol. Psychiatry 56 (2004) 18-23
33. (2+) influx. Cell. Calcium 33 (2003) 283-292
34. Shaltiel G., Maeng S., Malkesman O., Pearson B., Schloesser R.J., Tragon T., Rogawski M., Gasior M., Luckenbaugh D., Chen G., and Manji H.K. Evidence for the involvement of the kainate receptor subunit GluR6 (GluK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol. Psychiatry 13 (2008) 858-872
35. Song D., Du T., Li B., Cai L., Gu L., Li H., Chen Y., Hertz L., and Peng L. Astrocytic alkalinization by therapeutically relevant lithium concentrations: implications for myo-inositol depletion. Psychopharmacology (Berl.) 200 (2008) 187-195
36. Strutz-Seebohm N., Seebohm G., Shumilina E., Mack A.F., Wagner H.J., Lampert A., Grahammer F., Henke G., Just L., Skutella T., Hollmann M., and Lang F. Glucocorticoid adrenal steroids and glucocorticoid-inducible kinase isoforms in the regulation of GluR6 expression. J. Physiol. 565 (2005) 391-401
37. Uzman J.A., Patil S., Uzgare A.R., and Sater A.K. The role of intracellular alkalinization in the establishment of anterior neural fate in Xenopus. Dev. Biol. 193 (1998) 10-20
38. Wilding T.J., Chai Y.H., and Huettner J.E. Inhibition of rat neuronal kainate receptors by cis-unsaturated fatty acids. J. Physiol. 513 (1998) 331-339
39. Wolfson M., Bersudsky Y., Zinger E., Simkin M., Belmaker R.H., and Hertz L. Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations. Brain Res. 855 (2000) 158-161
40. Woo T.U., Shrestha K., Amstrong C., Minns M.M., Walsh J.P., and Benes F.M. Differential alterations of kainate receptor subunits in inhibitory interneurons in the anterior cingulate cortex in schizophrenia and bipolar disorder. Schizophr. Res. 96 (2007) 46-61